Alice Wei
Co-Director, Surgical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research · New York Presbyterian Hospital
Credentials: · · · · · · ·
History
PresentSurgical Initiatives · New York Presbyterian Hospital
- 2002–2003
- 1991–1995
Research
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
New England Journal of Medicine · 2018 · 2,279 citations
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Hepatology · 2023 · 1,671 citations
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
Nature · 2023 · 1,126 citations
- WJ
122 papers
- MD
108 papers
- PK
100 papers
- JD
94 papers
- KS
90 papers · 6 as a fellow
89 papers
- EO
48 papers
- SC
42 papers · 3 as a resident
Grants
- 2022–2027
The Memorial Sloan Kettering Cancer Center SPORE in Pancreas Cancer
National Cancer Institute · P50
Project lead · $3.2M · Sloan-Kettering Inst Can Research
Clinical trials
- 2023–2027
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
- 2022–2024
Virtual Mind-Body Exercises for People Having Pancreatic Surgery
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
- 2007–2014
Combined Resection of Colorectal Metastases
Principal investigator · Completed · Phase 2
University Health Network, Toronto